Announce Date | 05/12/2025 |
EPS Normalized Actual | $-0.11 (Beat by $0.04) |
EPS GAAP Actual | $-0.11 (Beat by $0.04) |
Revenue Actual | $0.013375B |
Revenue Surprise | Beat by $13.375M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.13101 |
EPS GAAP Estimate | $-0.13101 |
Revenue Estimate | $0.010865625B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | -0.26 | -138.92 | -0.42112 | -0.16755 | 1 |
Dec 2028 | -0.23 | -157.04 | -0.36114 | -0.17082 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.11 | 0.02174 | 0.013375B | 89.69% | 3.05M |
FQ4 2024 (Dec 2024) | -0.69 | -0.55695 | 0.034224B | 86.68% | 22.85M |
FQ3 2024 (Sep 2024) | -0.18 | -1.72141 | 0.000475B | -1363.16% | -12.56M |
FQ2 2024 (Jun 2024) | -0.31 | -0.31 | 0.000967B | -499.28% | 0.97M |
FQ1 2024 (Mar 2024) | -0.21 | -0.21 | 0.001379B | -299.2% | 1.38M |
FQ4 2023 (Dec 2023) | -0.24 | -0.24 | 0.00456B | 100% | 4.56M |
FQ3 2023 (Sep 2023) | -0.26 | -0.26 | 0.00695B | 100% | 6.95M |
FQ1 2021 (Mar 2021) | 0.0002 | 0.0002 | 0B | NAN% | 0M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.13101
Consensus Revenue Estimates
0.010865625B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | -0.1491 | -- | -0.1491 | -0.1491 | 1 |
FQ2 2027 (Jun 2027) | -0.1471 | -- | -0.1471 | -0.1471 | 1 |
FQ1 2027 (Mar 2027) | -0.1452 | -- | -0.1452 | -0.1452 | 1 |
FQ3 2026 (Sep 2026) | -0.11 | -- | -0.13562 | -0.0843831 | 1 |
FQ2 2026 (Jun 2026) | -0.11 | -- | -0.13562 | -0.0843831 | 1 |
FQ1 2026 (Mar 2026) | -0.11 | 0 | -0.13562 | -0.0843831 | 1 |
FQ4 2025 (Oct 2025) | -0.1281 | -438.64 | -0.13874 | -0.11746 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 2 |
FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 2 |
FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 3 |
FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 1 |
FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 1 |
FQ1 2026 (Mar 2026) | 0B | -568.75 | 0B | 0B | 1 |
FQ4 2025 (Oct 2025) | 0.01B | -162.63 | 0.01B | 0.01B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.13174 | -0.11 | 0.02174 | -19.76% |
FQ4 2024 (Dec 2024) | -0.13305 | -0.69 | -0.55695 | 80.72% |
FQ3 2024 (Sep 2024) | 1.54141 | -0.18 | -1.72141 | 956.34% |
FQ2 2024 (Jun 2024) | -0.31 | -0.31 | 100% | |
FQ1 2024 (Mar 2024) | -0.21 | -0.21 | 100% | |
FQ4 2023 (Dec 2023) | -0.24 | -0.24 | 100% | |
FQ3 2023 (Sep 2023) | -0.26 | -0.26 | 100% | |
FQ1 2021 (Mar 2021) | 0.0002 | 0.0002 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.01B | $0.01B | $3.05M | 22.83% |
FQ4 2024 (Dec 2024) | $0.01B | $0.03B | $22.85M | 66.76% |
FQ3 2024 (Sep 2024) | $0.01B | $0B | $-12.56M | -2645% |
FQ2 2024 (Jun 2024) | $0B | $0B | $0.97M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0B | $1.38M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0B | $4.56M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.01B | $6.95M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0B | $0M | NAN% |